Skip to main content

Table 6 Side effects observed

From: Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes

Side effects observed

NT n (%)

TNTn (%)

Deranged liver function tests

01 (1.6)

01 (5.8)

Oral mucositis

02 (3.3)

03(17.6)

Diarrhea

04 (6.6)

01 (5.8)

Neuropathy

15 (25)

04 (23.5)

Thrombocytopenia

03 (5)

0

Skin manifestations

01 (1.6)

01(5.8)

Urinary tract infection

02(3.3)

01 (5.8)

Sexual problem

Not known

Not Known

None

13 (21.6)

05 (29.4)